DERAZANTINIB HYDROCHLORIDE
UNII U6B7J0L31Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Derazantinib Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U6B7J0L31Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1821329-75-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U6B7J0L31Q

CAS Registry Number

1821329-75-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DERAZANTINIB HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H29FN4O.2ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OLDWOVJAXRWCGT-FBHGDYMESA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C143047

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

124081779

Unique identification number in the NCBI database of chemical substances.

USAN ID

FG-225

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c2-c3c([C@@H](Cc2cnc1Nc4cc(ccc4)CCNCCOC)c5c(cccc5)F)cccc3.Cl.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Derazantinib Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.